Skip to main content
All lobbying filings

JIM MASSIE & PARTNERS, LLC

JIM MASSIE & PARTNERS, LLC filed a Q3 report for COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS on October 20, 2025, reporting $50,000 in lobbying income.

Lobbying for COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS · Trade association representing the radionuclide and radiopharmaceutical industry.

All filings by JIM MASSIE & PARTNERS, LLC · Everything COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 20, 2025
Income
$50,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2

Proposed legislation to reauthorize the DOE Isotope Program Appropriations for DOE isotope production Legislation impacting the production and distribution of radiopharmaceuticals S.1241 - Sanctioning Russia Act of 2025

Issues related to the impact of tariffs on the availability of industrial and medical isotopes.

 Bills named in this filing 1
  • S. 1241
    Sanctioning Russia Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem